RESTORE Clinical Trial for Back Pain- Sydney

The RESTORE clinical trial is a large scale research study in Australia exploring back pain treatments. We are trying to measure how effective existing treatments are for people with persistent …

CONDITION: Musculoskeletal

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

The RESOLVE Trial: Retraining the brain to reduce pain intensity of chronic low back pain – RECRUITMENT COMPLETED

We have completed recruitment for the ‘RESOLVE trial for chronic low back pain’, a commonwealth government funded randomised controlled trial in which we are investigating the effectiveness of new treatment …

CONDITION: Musculoskeletal

GENDER: Both males and females

AGE GROUP: 18 to 70 years

TRIAL STATUS: Closed: follow-up continuing

Probiotic Clinical Trial

Are you in Good Health? Are you aged 18 or over? Do you live in Sydney? You may qualify* to take part in a trial looking at the potential changes …

CONDITION: Oral and Gastrointestinal

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

LE16053 Healthy Volunteer Trial

This is an open label, phase I study assessing the safety and tolerability of a pharmaceutical formulation comprising a protein that is being developed as a treatment for acute ischemic stroke. …

CONDITION:

GENDER: Both males and females

AGE GROUP: 18 to 50 years

TRIAL STATUS: Closed: follow-up continuing

Genital Psoriasis

Genital Psoriasis  If you have psoriasis with genital involvement, you’re not alone. Up to two thirds of people with psoriasis report genital involvement at some point during their lives. That’s …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

COPD – FLASH Study

 If you answered yes to these questions, you may be able to take part in a new research study.   Our Research Centre in Drummoyne is participating in the study. …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing